Literature DB >> 18717680

Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial.

K Mosterd1, M R T M Thissen, P Nelemans, N W J Kelleners-Smeets, R L L T Janssen, K G M E Broekhof, H A M Neumann, P M Steijlen, D I M Kuijpers.   

Abstract

BACKGROUND: Skin cancer incidence rates have been increasing for decades and this increase is expected to continue. Surgical excision (SE) is the treatment of first choice for nodular basal cell carcinoma (nBCC). Photodynamic therapy (PDT) has proven to be an effective treatment for superficial basal cell carcinoma. Its long-term efficacy in nBCC has not yet been established.
OBJECTIVES: Prospectively compare the efficacy of 5-aminolaevulinic acid (ALA)-PDT and SE in terms of failure rates with long-term follow-up. Determinants of failure in the study population, such as the effect of tumour depth, were analysed retrospectively.
METHODS: A randomized controlled trial in 173 primary nBCCs in 149 patients. Primary nBCCs were randomly assigned either to PDT (n = 85) or to SE (n = 88). Tumours treated with PDT were illuminated twice on the same day, 4 h after application of ALA cream, 3 weeks after debulking. SE was performed under local anaesthesia with a 3-mm margin, followed by histological examination. An intention-to-treat analysis was performed.
RESULTS: In total, 171 primary nBCCs in 149 patients were treated. A 3-year interim analysis revealed that the cumulative incidence of failure was 2.3% for SE and 30.3% for PDT (P < 0.001). Tumour depth and other analysed determinants of failure were not significantly related to treatment failure.
CONCLUSIONS: SE proved to be significantly more effective than treatment with fractionated illumination ALA-PDT. Therefore, in the treatment of primary nBCC, SE is preferred over PDT following this treatment regimen.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18717680     DOI: 10.1111/j.1365-2133.2008.08787.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  18 in total

Review 1.  Diagnosis and Management of Basal Cell Carcinoma.

Authors:  Keiji Tanese
Journal:  Curr Treat Options Oncol       Date:  2019-02-11

2.  Aminolevulinic acid-photodynamic therapy combined with topically applied vascular disrupting agent vadimezan leads to enhanced antitumor responses.

Authors:  Allison Marrero; Theresa Becker; Ulas Sunar; Janet Morgan; David Bellnier
Journal:  Photochem Photobiol       Date:  2011-06-13       Impact factor: 3.421

Review 3.  Photodynamic therapy of cancer: an update.

Authors:  Patrizia Agostinis; Kristian Berg; Keith A Cengel; Thomas H Foster; Albert W Girotti; Sandra O Gollnick; Stephen M Hahn; Michael R Hamblin; Asta Juzeniene; David Kessel; Mladen Korbelik; Johan Moan; Pawel Mroz; Dominika Nowis; Jacques Piette; Brian C Wilson; Jakub Golab
Journal:  CA Cancer J Clin       Date:  2011-05-26       Impact factor: 508.702

Review 4.  Basal cell carcinoma.

Authors:  Anthony Ormerod; Sanjay Rajpara; Fiona Craig
Journal:  BMJ Clin Evid       Date:  2010-04-06

Review 5.  Basal Cell Carcinoma: A Comprehensive Review of Existing and Emerging Nonsurgical Therapies.

Authors:  Julien Lanoue; Gary Goldenberg
Journal:  J Clin Aesthet Dermatol       Date:  2016-05-01

6.  Blue light versus red light for photodynamic therapy of basal cell carcinoma in patients with Gorlin syndrome: A bilaterally controlled comparison study.

Authors:  Edward V Maytin; Urvashi Kaw; Muneeb Ilyas; Judith A Mack; Bo Hu
Journal:  Photodiagnosis Photodyn Ther       Date:  2018-02-19       Impact factor: 3.631

7.  No-needle jet intradermal aminolevulinic Acid photodynamic therapy for recurrent nodular Basal cell carcinoma of the nose: a case report.

Authors:  Daniel Barolet; Annie Boucher
Journal:  J Skin Cancer       Date:  2010-10-18

8.  Pre-treatment deep curettage can significantly reduce tumour thickness in thick Basal cell carcinoma while maintaining a favourable cosmetic outcome when used in combination with topical photodynamic therapy.

Authors:  Eidi Christensen; Cato Mørk; Olav Andreas Foss
Journal:  J Skin Cancer       Date:  2011-11-15

Review 9.  Photodynamic therapy in the treatment of basal cell carcinoma.

Authors:  C Matei; M Tampa; T Poteca; G Panea-Paunica; S R Georgescu; R M Ion; S M Popescu; C Giurcaneanu
Journal:  J Med Life       Date:  2013-03-25

10.  Interventions for basal cell carcinoma of the skin.

Authors:  Jason Thomson; Sarah Hogan; Jo Leonardi-Bee; Hywel C Williams; Fiona J Bath-Hextall
Journal:  Cochrane Database Syst Rev       Date:  2020-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.